Functional Recovery of Patients Undergoing Resection and Reconstruction of the Lower Limbs for Bone Tumor. (FISIO-ONCO)

February 2, 2026 updated by: Istituto Ortopedico Rizzoli

Functional Recovery in the First Six Postoperative Months of Cancer Patients Undergoing Lower Limb Resection and Reconstruction. An Observational Study

The aim of the present study is to describe the course of functional recovery of patients with musculoskeletal tumours and undergone resection and reconstruction operations of lower limbs in the first six months post-surgery, differentiating them on the basis of the anatomical level involved.

Study Overview

Status

Completed

Detailed Description

Retrospective observational study will be conducted. The evaluation of the patients clinical recovery progress will take place at three different times: during the hospital stay postoperative, at 3 and 6 months after surgery. Different outcome measures will be considered in order to provide a complete picture of the patients functional recovery and their change.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bologna, Italy, 40136
        • Istituto Ortopedico Rizzoli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All participants with bone tumor diagnosis treated at the hospital

Description

Inclusion Criteria:

  • All participants undergone lower limb resection and reconstruction with localisation of the disease to the pelvis, femur femur, tibia and foot bones.
  • All participants undergone soft tissue resection surgery on the of the lower limb
  • All types of oncological diagnoses will be taken considered: osteosarcoma, Ewing and others.

Exclusion Criteria:

  • Participants who undergo at our Institute only the surgical treatment while continuing adjuvant treatment at other centres
  • Participants for whom no rehabilitation treatment has been activated during adjuvant treatment at our Institute

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Toronto Extremity Salvage Score (TESS)
Time Frame: at 3 months after surgery
Person's level of independence. It is measured through 30 questions relating to 30 activities of daily living to be answered by the patient. The total score is reported from 0 to 100. A higher score indicates a greater degree of autonomy. A higher score indicates a greater degree of autonomy.
at 3 months after surgery
Toronto Extremity Salvage Score (TESS)
Time Frame: at 6 months after surgery
Person's level of independence. It is measured through 30 questions relating to 30 activities of daily living to be answered by the patient. The total score is reported from 0 to 100. A higher score indicates a greater degree of autonomy. A higher score indicates a greater degree of autonomy.
at 6 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion (ROM)
Time Frame: at 3 months after surgery
The range of motion of the main joints of the lower limbs (hip, knee or foot), measured with a goniometer
at 3 months after surgery
Rang of motion - 2 (ROM)
Time Frame: at 6 months after surgery
The range of motion of the main joints of the lower limbs (hip, knee or foot), measured with a goniometer
at 6 months after surgery
Number of participants able to walk
Time Frame: up to 1 week
Number of participant that are able to walk and aids used for walking
up to 1 week
Time Up and Go -2 (TUG)
Time Frame: at 3 months after surgery
Time it takes a person to get up from a chair, walk three metres, turn around, return to the chair and sit down again is measured.
at 3 months after surgery
Time Up and Go (TUG)
Time Frame: at 6 months after surgery
Time it takes a person to get up from a chair, walk three metres, turn around, return to the chair and sit down again is measured.
at 6 months after surgery
Muscle Strength
Time Frame: at 3 months after surgery
Grades of Muscle Strength from 0 (no contraction) to 5 (best strength)
at 3 months after surgery
Muscle Strength-2
Time Frame: at 6 months after surgery
Grades of Muscle Strength from 0 (no contraction) to 5 (best strength)
at 6 months after surgery
Number of day from surgery to first walking
Time Frame: up to 1 week
The number of day that participants needs to recover ambulation after surgery
up to 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2024

Primary Completion (Actual)

January 31, 2026

Study Completion (Actual)

January 31, 2026

Study Registration Dates

First Submitted

April 15, 2024

First Submitted That Met QC Criteria

April 18, 2024

First Posted (Actual)

April 19, 2024

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CEAVEC: 111/2024/Oss/IOR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Subscribe